Daily News & Industry Trends

Vaxiflu 2026–27: What to Know About Zydus’s Flu Vaccine

Vaxiflu 2026–27 is an inactivated influenza vaccine marketed by Zydus in India. Current product information describes it as a trivalent vaccine covering influenza A(H1N1), A(H3N2) and B/Victoria, while global 2026–27 guidance continues to recommend annual influenza vaccination for eligible people aged 6 months and older.